TSXV:VHI

Stock Analysis Report

Executive Summary

VitalHub Corp., together with its subsidiaries, develops and supports healthcare information systems in the mental health, long term care, community health service, and hospital sectors in Canada and the United States.

Snowflake

Fundamentals

Adequate balance sheet and slightly overvalued.


Similar Companies

Share Price & News

How has Vitalhub's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: VHI has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

2.8%

VHI

2.8%

CA Healthcare Services

0.3%

CA Market


1 Year Return

8.8%

VHI

12.7%

CA Healthcare Services

8.5%

CA Market

Return vs Industry: VHI exceeded the Canadian Healthcare Services industry which returned 12.7% over the past year.

Return vs Market: VHI exceeded the Canadian Market which returned 8.5% over the past year.


Shareholder returns

VHIIndustryMarket
7 Day2.8%2.8%0.3%
30 Day19.4%5.0%3.1%
90 Day15.6%32.0%3.6%
1 Year8.8%8.8%12.7%12.7%12.1%8.5%
3 Yearn/a20.2%20.2%16.4%6.0%
5 Yearn/a62.1%60.7%27.3%8.7%

Price Volatility Vs. Market

How volatile is Vitalhub's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Vitalhub undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: VHI (CA$0.19) is trading below our estimate of fair value (CA$0.53)

Significantly Below Fair Value: VHI is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: VHI is unprofitable, so we can't compare its PE Ratio to the Healthcare Services industry average.

PE vs Market: VHI is unprofitable, so we can't compare its PE Ratio to the Canadian market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate VHI's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: VHI is overvalued based on its PB Ratio (2.2x) compared to the CA Healthcare Services industry average (1.9x).


Next Steps

Future Growth

How is Vitalhub forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

18.8%

Forecasted annual revenue growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if VHI's forecast earnings growth is above the savings rate (1.9%).

Earnings vs Market: Insufficient data to determine if VHI's earnings are forecast to grow faster than the Canadian market

High Growth Earnings: Insufficient data to determine if earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: VHI's revenue (18.8% per year) is forecast to grow faster than the Canadian market (4.7% per year).

High Growth Revenue: VHI's revenue (18.8% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if VHI's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has Vitalhub performed over the past 5 years?

13.6%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: VHI has large one-off items impacting its financial results.

Growing Profit Margin: VHI is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: VHI is unprofitable, but has reduced losses over the past 5 years at a rate of 13.6% per year.

Accelerating Growth: Unable to compare VHI's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: VHI is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (-0.2%).


Return on Equity

High ROE: VHI has a negative Return on Equity (-4.06%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Next Steps

Financial Health

How is Vitalhub's financial position?


Financial Position Analysis

Short Term Liabilities: VHI's short term assets (CA$7.9M) exceeds its short term liabilities (CA$6.3M)

Long Term Liabilities: VHI's short term assets (CA$7.9M) exceeds its long term liabilities (3.9M)


Debt to Equity History and Analysis

Debt Level: VHI's debt to equity ratio (16.9%) is considered satisfactory.

Reducing Debt: Insufficient data to determine if VHI's debt to equity ratio has reduced over the past 5 years.


Balance Sheet

Inventory Level: VHI has a low level of unsold assets or inventory.

Debt Coverage by Assets: VHI's debt is covered by short term assets (assets are 3.4x debt).


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: VHI has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if VHI has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Next Steps

Dividend

What is Vitalhub's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%2.0%markettop25%5.8%industryaverage0.7%forecastin3Yearsn/a

Current dividend yield vs market & industry

Notable Dividend: Unable to evaluate VHI's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate VHI's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if VHI's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if VHI's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of VHI's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.


Next Steps

Management

What is the CEO of Vitalhub's salary, the management and board of directors tenure and is there insider trading?

2.8yrs

Average management tenure


CEO

Dan Matlow (56yo)

3yrs

Tenure

CA$324,696

Compensation

Mr. Daniel Matlow, also known as Dan, has been the President and Chief Executive Officer at VitalHub Corp. since November 28, 2016. Mr. Matlow served as the Chief Executive Officer and President of Medworx ...


CEO Compensation Analysis

Compensation vs Market: Dan's total compensation ($USD245.46K) is above average for companies of similar size in the Canadian market ($USD136.08K).

Compensation vs Earnings: Dan's compensation has increased whilst the company is unprofitable.


Management Age and Tenure

2.8yrs

Average Tenure

Experienced Management: VHI's management team is considered experienced (2.8 years average tenure).


Board Age and Tenure

3.0yrs

Average Tenure

61.5yo

Average Age

Experienced Board: VHI's board of directors are considered experienced (3 years average tenure).


Insider Trading

Insider Buying: VHI insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

BuyCA$16,86830 Sep 19
Francis Shen
EntityIndividual
Role
Member of the Board of Directors
Director
Shares90,000
Max PriceCA$0.19
BuyCA$345,35606 Sep 19
Francis Shen
EntityIndividual
Role
Member of the Board of Directors
Director
Shares1,935,000
Max PriceCA$0.18
BuyCA$199,80004 Sep 19
Francis Shen
EntityIndividual
Role
Member of the Board of Directors
Director
Shares1,110,000
Max PriceCA$0.18

Ownership Breakdown

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 84%.


Management Team

  • Dan Matlow (56yo)

    President

    • Tenure: 3yrs
    • Compensation: CA$324.70k
  • Niels Tofting

    Executive Vice President of Business Development & Marketing

    • Tenure: 2yrs
    • Compensation: CA$244.72k
  • Brian Goffenberg

    CFO & Executive VP

    • Tenure: 3yrs
    • Compensation: CA$246.64k
  • Robert Lazar

    Executive Vice President of Professional Services & Support

    • Tenure: 2.8yrs
  • Vijit Coomara

    Executive Vice President of Product Development

    • Tenure: 2.8yrs
    • Compensation: CA$227.50k

Board Members

  • Chris Schnarr (52yo)

    Independent Director

    • Tenure: 2.9yrs
    • Compensation: CA$13.13k
  • Francis Shen (61yo)

    Director

    • Tenure: 0.5yrs
  • Tony Shen (62yo)

    Board Observer

    • Tenure: 0.5yrs
  • Steve Garrington (64yo)

    Independent Director

    • Tenure: 3yrs
    • Compensation: CA$7.50k
  • Dan Matlow (56yo)

    President

    • Tenure: 3yrs
    • Compensation: CA$324.70k
  • Roger Dent

    Independent Director

    • Tenure: 4.8yrs
    • Compensation: CA$13.13k
  • Barry Tissenbaum (74yo)

    Independent Director

    • Tenure: 3yrs
    • Compensation: CA$13.13k

Company Information

Vitalhub Corp.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Vitalhub Corp.
  • Ticker: VHI
  • Exchange: TSXV
  • Founded:
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Market Cap: CA$30.582m
  • Shares outstanding: 165.31m
  • Website: https://vitalhub.com

Number of Employees


Location

  • Vitalhub Corp.
  • 480 University Avenue
  • Suite 1001
  • Toronto
  • Ontario
  • M5G 1V2
  • Canada

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
VHITSXV (TSX Venture Exchange)YesClass A SharesCACADNov 2016
6OVDB (Deutsche Boerse AG)YesClass A SharesDEEURNov 2016

Biography

VitalHub Corp., together with its subsidiaries, develops and supports healthcare information systems in the mental health, long term care, community health service, and hospital sectors in Canada and the U ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/11/20 00:49
End of Day Share Price2019/11/19 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.